Vitamin B6 For All Inflammatory Conditions And Cancer

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe
It looks like there is a strong push to patent derivatives of P5P for treatment of virtually all types of inflammatory conditions, and prevention of cancer. P5P even has anti-depressant and anti-seizure activities. The mechanism of action is antagonism of the P2X "receptors" and according to the studies P5P is a general and potent antagonist on the entire family of P2X "receptors". Thus, is could be the basis of the new wave of pharma drugs for all inflammatory conditions and cancer.

http://onlinelibrary.wiley.com/doi/10.1002/wmts.1/pdf
http://patentscope.wipo.int/search/en/WO2006136004
http://cdn.intechopen.com/pdfs-wm/24637.pdf
http://jpet.aspetjournals.org/content/295/3/862.long
 

aguilaroja

Member
Joined
Jul 24, 2013
Messages
850
haidut said:
...The mechanism of action is antagonism of the P2X "receptors" and according to the studies P5P is a general and potent antagonist on the entire family of P2X "receptors"....

This recent review is the best listing of some of the P2X7 pathway interests that I have seen:

http://www.ncbi.nlm.nih.gov/pubmed/25223574
Trends Pharmacol Sci. 2014 Oct;35(10):537-547. doi: 10.1016/j.tips.2014.08.002.
P2X7 receptor: an emerging target in central nervous system diseases.
Sperlágh B1, Illes P2.

Abstract
The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.
 
Joined
Nov 26, 2013
Messages
7,370
Can you imagine the war they will wage against natural B6?
 

DrG

New Member
Joined
Oct 15, 2014
Messages
4
Haidut - Are you making the cancer reduction connection on the general basis of inflammation reduction? Or are there specific studies relevant to cancer?
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,799
Location
USA / Europe
DrG said:
Haidut - Are you making the cancer reduction connection on the general basis of inflammation reduction? Or are there specific studies relevant to cancer?

Both - there are specific studies on B6/P5P and pancreatic cancer as well as several others, and there is also the inflammation factor too. The studies I posted above discuss both aspects - the specific anti-cancer mechanisms and the anti-inflammatory activity.
 

ddjd

Member
Joined
Jul 13, 2014
Messages
6,722
It looks like there is a strong push to patent derivatives of P5P for treatment of virtually all types of inflammatory conditions, and prevention of cancer. P5P even has anti-depressant and anti-seizure activities. The mechanism of action is antagonism of the P2X "receptors" and according to the studies P5P is a general and potent antagonist on the entire family of P2X "receptors". Thus, is could be the basis of the new wave of pharma drugs for all inflammatory conditions and cancer.

Error - Cookies Turned Off
WO2006136004 INHIBITION OF ATP-MEDIATED, P2X7 DEPENDENT PATHWAYS BY PYRIDOXAL-5-PHOSPHASTE AND VITAMIN B6 RELATED COMPOUNDS
http://cdn.intechopen.com/pdfs-wm/24637.pdf
P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential

would regular b6 not have the same effect??

not sure about the credibility of this study but its suggesting potential 4x risk of lung cancer from taking daily b6
https://cancer.osu.edu/news/long-te...ted-with-increased-lung-cancer-risk-among-men
 

orewashin

Member
Joined
Jun 16, 2020
Messages
327

Amazoniac

Member
Joined
Sep 10, 2014
Messages
8,583
Location
Not Uganda
- Antitumor effect of vitamin B6 and its mechanisms

Abstract said:
Epidemiological studies have reported an inverse association between vitamin B6 intake and colon cancer risk. Our recent study has been conducted to examine the effect of dietary vitamin B6 on colon tumorigenesis in mice. Mice were fed diets containing 1, 7, 14 or 36 mg/kg pyridoxine for 22 weeks, and given a weekly injection of azoxymethane (AOM) for the initial 10 weeks. Compared with the 1 mg/kg pyridoxine diet, 7, 14 and 35 mg/kg pyridoxine diets significantly suppressed the incidence and number of colon tumors, colon cell proliferation and expressions of c-myc and c-fos proteins. Supplemental vitamin B6 lowered the levels of colonic 8-hydroxyguanosine (8-OHdG), 4-hydroxy-2-nonenal (4-HNE, oxidative stress markers) and inducible nitric oxide (NO) synthase protein. In an ex vivo serum-free matrix culture model using rat aortic ring, supplemental pyridoxine and pyridoxal 5′-phosphate (PLP) had antiangiogenic effect. The results suggest that dietary vitamin B6 suppresses colon tumorigenesis by reducing cell proliferation, oxidative stress, NO production and angiogenesis.
 
EMF Mitigation - Flush Niacin - Big 5 Minerals

Similar threads

Back
Top Bottom